More Than A Cure
As the world continues to live in the new normal, there are indications that the dark clouds might clear anytime soon, at least with the help of science and the unrelenting strive of humanity to save the world.
As the world continues to live in the new normal, there are indications that the dark clouds might clear anytime soon, at least with the help of science and the unrelenting strive of humanity to save the world.
While you were planning to go to bed yesterday in Nigeria, over the Atlantic, the US announced a therapeutic 'breakthrough' for the treatment of patients with COVID-19. The treatment relies on blood plasma from recovered coronavirus patients.
Such Plasma is believed to contain powerful antibodies that can help fight off the disease faster and help protect people from being seriously hurt by it.
“This product may be effective in treating COVID-19 and… the known and potential benefits of the product outweigh the known and potential risks of the product,” FDA said in a statement.
However, it is still very much a gleaner of hope, experts warned that the extent of its effectiveness is still debatable and some have warned that it could carry side effects.
“Convalescent plasma probably works — though it still needs to be proven in clinical trials — but not as a rescue treatment for people who are already severely ill,” said Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City.
He said that plasma would likely work much better right after a person was exposed to the virus when the body is trying to neutralize the infection.
Even if this does not mean that the 'storm is over', there is a consensus amongst experts in human and medical science that it could be a viable stopgap we can rely on to reduce the wanton loss of lives to the virus.
Bring it all together
Bring it all together
There is no doubt about it that the global economy would react positively to this new treatment.
While this is still a temporal measure to save lives, businesses and brands should perhaps get ready for at least a vaccine which experts project could be with us in the next four to five months (all other things being equal).
However, because this is not a vaccine and because the knowledge of the treatment (procedure) is owned by the US, (at least for now), brands should in the meantime, continue to focus on marketing and communication channels that ensure social distancing,
prioritize experience and customer satisfaction.
For instance, you can opt for a physical event with minimal human presence blended with scripted virtual contents that can involve hundreds of actively engaged participants. In the early days of the global lockdown,
For instance, you can opt for a physical event with minimal human presence blended with scripted virtual contents that can involve hundreds of actively engaged participants. In the early days of the global lockdown,
we have executed top-notch events using this model and recently. Last week, the world witnessed a larger scale of such an approach in the US Democratic National Convention (DNC).
The import of this is that we should be more confident to make things happen through innovation and teamwork, we might not have a silver-bullet cure, but many brands are now living the new-normal and thriving.
The question is, are you ready? You can talk to us on how you can master the new-normal with marketing and communication innovations and tools, we are just an email away - info@sbimedia.com.ng
Don't forget to follow all the hygiene and safety precautions to protect yourself from the virus. Be safe!
#MondayMotivation #MondayMorning #SBIMedia
#MondayMotivation #MondayMorning #SBIMedia
